Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine

Detalles Bibliográficos
Autores principales: D’Agati, Vivette D., Kudose, Satoru, Bomback, Andrew S., Adamidis, Ananea, Tartini, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123374/
https://www.ncbi.nlm.nih.gov/pubmed/34000278
http://dx.doi.org/10.1016/j.kint.2021.04.035
_version_ 1783692886448013312
author D’Agati, Vivette D.
Kudose, Satoru
Bomback, Andrew S.
Adamidis, Ananea
Tartini, Albert
author_facet D’Agati, Vivette D.
Kudose, Satoru
Bomback, Andrew S.
Adamidis, Ananea
Tartini, Albert
author_sort D’Agati, Vivette D.
collection PubMed
description
format Online
Article
Text
id pubmed-8123374
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-81233742021-05-17 Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine D’Agati, Vivette D. Kudose, Satoru Bomback, Andrew S. Adamidis, Ananea Tartini, Albert Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-08 2021-05-15 /pmc/articles/PMC8123374/ /pubmed/34000278 http://dx.doi.org/10.1016/j.kint.2021.04.035 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
D’Agati, Vivette D.
Kudose, Satoru
Bomback, Andrew S.
Adamidis, Ananea
Tartini, Albert
Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
title Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
title_full Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
title_fullStr Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
title_full_unstemmed Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
title_short Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
title_sort minimal change disease and acute kidney injury following the pfizer-biontech covid-19 vaccine
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123374/
https://www.ncbi.nlm.nih.gov/pubmed/34000278
http://dx.doi.org/10.1016/j.kint.2021.04.035
work_keys_str_mv AT dagativivetted minimalchangediseaseandacutekidneyinjuryfollowingthepfizerbiontechcovid19vaccine
AT kudosesatoru minimalchangediseaseandacutekidneyinjuryfollowingthepfizerbiontechcovid19vaccine
AT bombackandrews minimalchangediseaseandacutekidneyinjuryfollowingthepfizerbiontechcovid19vaccine
AT adamidisananea minimalchangediseaseandacutekidneyinjuryfollowingthepfizerbiontechcovid19vaccine
AT tartinialbert minimalchangediseaseandacutekidneyinjuryfollowingthepfizerbiontechcovid19vaccine

Ejemplares similares